54
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia

ORCID Icon, , , , , , , , & show all
Received 09 Nov 2023, Accepted 12 Mar 2024, Published online: 21 Mar 2024
 

Ethical approval

This study was approved by the Scientific Advisory Committee (SMAC) and the Institutional Review Board (IRB). Informed consent was obtained before diagnostic assessment or therapy was initiated.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

Data used to support the findings of this study are available from the corresponding author upon request.

Additional information

Funding

This research did not receive external funding.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.